Anthony Johnson

Anthony Johnson is an experienced executive with a strong track record of leadership across the healthcare sector. His experience has covered a multitude of areas inclusive of sales, marketing and strategy and business development. Having lived and worked in Europe, South America and the USA Mr. Johnson brings an international perspective and diversity of domestic and international experiences to his work.

Anthony is the former President/CEO of Empire Genomics, a pre-eminent oncology genomic molecular diagnostic company. As the founding CEO of Empire he led the business through multiple funding rounds, acquisitions, licensing in addition to staffing and setting business strategy. Under his guidance Empire was able to launch companion diagnostic assays, obtain CAP and CLIA certifications, CE marking and move 3 times to accommodate business growth. Anthony also founded Buffalo Biosciences, (BBS) a technology investment and management services firm. At BBS Anthony worked with clients including tech transfer offices, numerous startups in addition to State and Local Governments to guide them in their focus on healthcare endeavors. A major accomplishment that Anthony led on behalf of BBS was the firms participation in the creation and launch of the New York Stem Cell Institute. Prior to Buffalo Biosciences he led the stem cell and cell therapy division for IVGN corporation. In this capacity he was responsible for sales, marketing and business development. In this role Mr. Johnson was responsible for IVGN’s participation in the creation of the California Institute for Regenerative Medicine, a $3 Billion dollar bond issuance to support stem cell research in the state.

Mr. Johnson holds a Bachelor’s Degree from Fisk University located in Nashville, TN and an MBA from Alliance Manchester Business School, Manchester England. He is a Fellow of the Aspen Institute’s Health Innovators Fellowship and member of the Aspen Global Leadership Network.